Related references
Note: Only part of the references are listed.FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
Marianne Sinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Does Size Matter in Pancreatic Cancer? Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM
Giovanni Marchegiani et al.
ANNALS OF SURGERY (2017)
MERAV: a tool for comparing gene expression across human tissues and cell types
Yoav D. Shaul et al.
NUCLEIC ACIDS RESEARCH (2016)
Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
Keisuke Taniuchi et al.
CANCER SCIENCE (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells
Makiko Tsuboi et al.
PANCREATOLOGY (2016)
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
Moh'd Khushman et al.
PANCREATOLOGY (2015)
Multi-institutional Pooled Analysis on Adjuvant Chemoradiation in Pancreatic Cancer
Alessio G. Morganti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer
Keisuke Taniuchi et al.
ONCOTARGET (2014)
KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells
Keisuke Taniuchi et al.
NEOPLASIA (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Molecular markers associated with outcome and metastasis in human pancreatic cancer
Anke Van den Broeck et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Knockdown of the β1 integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis
John J. Grzesiak et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CUB Domain-Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
Yuri Miyazawa et al.
CANCER RESEARCH (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clinicopathological correlates of pancreatic intraepithelial neoplasia: A comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma
A Andea et al.
MODERN PATHOLOGY (2003)
β1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells
S Arao et al.
PANCREAS (2000)
Share Paper
